Section 174A and startup cash planning

For tax years beginning after December 31, 2024, Section 174A — enacted in the One Big Beautiful Bill Act — lets startups deduct domestic research or experimental expenditures immediately, ending the 2022–2024 capitalization regime that generated phantom taxable income at loss-making companies. For most startups the planning answer is simple: expense. But the statute's alternative — electing to capitalize and amortize over at least 60 months — is not a trap; it is occasionally the better cash answer.

Expensing restored: the default case

A startup spending $2M on domestic engineering deducts $2M in the year spent. Foreign research — including offshore development contractors — remains capitalized over 15 years under Section 174, a distinction that matters at diligence and is unchanged by the OBBBA. Small businesses (average annual gross receipts of $31M or less) may also apply Section 174A retroactively to 2022–2024 by amended return, and all taxpayers may deduct remaining unamortized domestic 2022–2024 amounts over one or two years; Pub 538 covers the method-change framework behind these transitions.

When the 60-month election is better

Immediate deductions at a company with no income buy nothing today — they build NOLs. Two features make NOLs worth less than face value:

• The 80% limitation. Post-2017 NOLs offset only 80% of taxable income in the year used, stretching recovery.
• Section 382 exposure. An ownership change — which a priced equity round can trigger — caps annual NOL usage at roughly the company's value times a published federal rate. A startup that raises at a modest valuation after accumulating large NOLs can strand most of them.

Electing 60-month amortization under Section 174A moves the deduction out of loss years and into (hoped-for) income years, sidestepping both problems. It is the right call mainly for companies with heavy R&E spend, near-term profitability, and a financing calendar likely to trip Section 382. For everyone else, deferral is just deferral.

The payroll offset stacks either way

The Section 41 payroll offset — up to $500,000 per year against employer payroll taxes for qualified small businesses — is computed from qualified research expenses, not from the deduction method. Expense under 174A, or amortize; the credit is the same. The offset is the piece that produces cash in year one for a pre-profit company, so it should anchor the plan regardless of the 174A choice.

Year-one cash, side by side

Illustrative year one for a pre-revenue startup with $2,000,000 of domestic R&E, $1,800,000 of it wage QREs, ASC credit at 6% (no prior QREs):

The table's point is deliberately anticlimactic: with no taxable income, the deduction method changes year-one cash by nothing. The payroll offset — claimed via Form 8974 after the election on the original return — is the only year-one cash item. The 174A choice is entirely about later years: where the $2M deduction lands, and whether NOLs survive the cap table.